Literature DB >> 32593855

Low muscle mass is associated with carotid atherosclerosis in patients with type 2 diabetes.

Da Hea Seo1, Yong-Ho Lee2, Young Ju Suh3, Seong Hee Ahn1, Seongbin Hong1, Young Ju Choi4, Byoung Wook Huh4, Seok Won Park2, Eunjig Lee2, So Hun Kim5.   

Abstract

BACKGROUND AND AIMS: Sarcopenia leads to metabolic and vascular abnormalities. However, little is known regarding the independent relationship between skeletal muscle mass and atherosclerosis in patients with type 2 diabetes mellitus (T2DM). This study aimed to evaluate the association between skeletal muscle mass and carotid atherosclerosis in men and women with T2DM.
METHODS: In this cross-sectional study, a total of 8202 patients with T2DM were recruited from the Seoul Metabolic Syndrome cohort. Skeletal muscle mass was estimated using bioimpedance analysis, while skeletal muscle mass index (SMI, %) was defined as total skeletal muscle mass (kg)/body weight (kg) × 100. Both carotid arteries were examined by B-mode ultrasound. Carotid atherosclerosis was defined by having a carotid plaque or mean carotid intima-media thickness (IMT) ≥1.1 mm.
RESULTS: Among the entire population, 4299 (52.4%) subjects had carotid atherosclerosis. The prevalence of carotid atherosclerosis increased with decreasing SMI quartiles for both sexes. The odds ratios for carotid atherosclerosis were 2.33 (95% confidence interval [CI], 1.17-4.63) and 2.24 (95% CI, 1.06-4.741) in the lowest versus highest SMI quartile in men and women, respectively, after the adjustment for clinical risk factors. In men, the risk of atherosclerosis increased linearly with decreasing SMI quartiles (p for trend = 0.036).
CONCLUSIONS: Low skeletal muscle mass was independently associated with the presence of carotid atherosclerosis in men and women with T2DM.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Artery plaque; Carotid; Carotid atherosclerosis; Carotid intima-media thickness; Diabetes mellitus; Muscle; Sarcopenia; Skeletal; Type 2

Mesh:

Year:  2020        PMID: 32593855     DOI: 10.1016/j.atherosclerosis.2020.05.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.

Authors:  Su Hwan Kim; Hyoun Woo Kang; Ji Bong Jeong; Dong Seok Lee; Dong-Won Ahn; Ji Won Kim; Byeong Gwan Kim; Kook Lae Lee; Sohee Oh; Soon Ho Yoon; Sang Joon Park
Journal:  PLoS One       Date:  2021-08-17       Impact factor: 3.240

Review 2.  Bioelectrical Impedance Analysis for the Assessment of Body Composition in Sarcopenia and Type 2 Diabetes.

Authors:  Stefano Sbrignadello; Christian Göbl; Andrea Tura
Journal:  Nutrients       Date:  2022-04-29       Impact factor: 6.706

3.  Association between sarcopenia level and metabolic syndrome.

Authors:  Su Hwan Kim; Ji Bong Jeong; Jinwoo Kang; Dong-Won Ahn; Ji Won Kim; Byeong Gwan Kim; Kook Lae Lee; Sohee Oh; Soon Ho Yoon; Sang Joon Park; Doo Hee Lee
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

4.  Carotid Artery Disease in Subjects with Type 2 Diabetes: Risk Factors and Biomarkers.

Authors:  Vadim V Klimontov; Elena A Koroleva; Rustam S Khapaev; Anton I Korbut; Alexander P Lykov
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

5.  Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes.

Authors:  Yoshitaka Hashimoto; Fuyuko Takahashi; Takuro Okamura; Takafumi Osaka; Hiroshi Okada; Takafumi Senmaru; Saori Majima; Emi Ushigome; Naoko Nakanishi; Mai Asano; Masahide Hamaguchi; Masahiro Yamazaki; Michiaki Fukui
Journal:  BMJ Open Diabetes Res Care       Date:  2022-06

6.  The relationship between the visceral adiposity index and carotid atherosclerosis in different genders and age groups.

Authors:  Jing Cao; Shengpeng Liu; Hebin Xie; Yu Zhang; Yalin Zeng
Journal:  Saudi Med J       Date:  2022-02       Impact factor: 1.422

7.  Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Min-Kyu Kang; Jung-Gil Park
Journal:  Diagnostics (Basel)       Date:  2021-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.